Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology

医学 氯吡格雷 卵圆孔未闭 冲程(发动机) 禁忌症 阿司匹林 神经血管束 介入心脏病学 心脏病学 外科 反常栓塞 内科学 经皮 替代医学 工程类 机械工程 病理
作者
Jean‐Louis Mas,Laurent Derex,Patrice Guérin,B. Guillon,Gilbert Habib,Jean‐Michel Juliard,Éloi Marijon,Evelyne Massardier,Nicolas Piriou,Fabrice Vuillier
出处
期刊:Revue Neurologique [Elsevier BV]
卷期号:176 (1-2): 53-61 被引量:7
标识
DOI:10.1016/j.neurol.2019.10.002
摘要

Summary Background Unlike previous randomized clinical trials (RCTs), recent trials and meta-analyses have shown that transcatheter closure of patent foramen ovale (PFO) reduces stroke recurrence risk in young and middle-aged adults with an otherwise unexplained PFO-associated ischaemic stroke. Aim To produce an expert consensus on the role of transcatheter PFO closure and antithrombotic drugs for secondary stroke prevention in patients with PFO-associated ischaemic stroke. Methods Five neurologists and five cardiologists with extensive experience in the relevant field were nominated by the French Neurovascular Society and the French Society of Cardiology to make recommendations based on evidence from RCTs and meta-analyses. Results The experts recommend that any decision concerning treatment of patients with PFO-associated ischaemic stroke should be taken after neurological and cardiological evaluation, bringing together the necessary neurovascular, echocardiography and interventional cardiology expertise. Transcatheter PFO closure is recommended in patients fulfilling all the following criteria: age 16–60 years; recent (≤ 6 months) ischaemic stroke; PFO associated with atrial septal aneurysm (> 10 mm) or with a right-to-left shunt > 20 microbubbles or with a diameter ≥ 2 mm; PFO felt to be the most likely cause of stroke after thorough aetiological evaluation by a stroke specialist. Long-term oral anticoagulation may be considered in the event of contraindication to or patient refusal of PFO closure, in the absence of a high bleeding risk. After PFO closure, dual anti-platelet therapy with aspirin (75 mg/day) and clopidogrel (75 mg/day) is recommended for 3 months, followed by monotherapy with aspirin or clopidogrel for ≥ 5 years. Conclusions Although a big step forward that will benefit many patients has been taken with recent trials, many questions remain unanswered. Pending results from further studies, decision-making regarding management of patients with PFO-associated ischaemic stroke should be based on a close coordination between neurologists/stroke specialists and cardiologists.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ELITOmiko发布了新的文献求助10
刚刚
等待蓝天发布了新的文献求助10
刚刚
wg发布了新的文献求助10
1秒前
深情安青的应助被科研通管家采纳,获得10
2秒前
2秒前
bkagyin的应助被科研通管家采纳,获得10
2秒前
luyue9406的应助被科研通管家采纳,获得10
2秒前
情怀的应助被科研通管家采纳,获得10
3秒前
顾矜的应助被科研通管家采纳,获得10
3秒前
3秒前
Akim的应助被科研通管家采纳,获得10
3秒前
3秒前
molihuakai的应助被科研通管家采纳,获得10
3秒前
Lemonhead的应助被科研通管家采纳,获得50
3秒前
天天快乐的应助被科研通管家采纳,获得50
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
华仔的应助被科研通管家采纳,获得10
4秒前
蓝桉的应助被科研通管家采纳,获得50
4秒前
67发布了新的文献求助10
4秒前
无极微光的应助被科研通管家采纳,获得20
4秒前
烟花的应助被科研通管家采纳,获得10
4秒前
orixero的应助被科研通管家采纳,获得10
4秒前
顾矜的应助被科研通管家采纳,获得30
5秒前
英姑的应助被科研通管家采纳,获得10
5秒前
5秒前
追寻思雁发布了新的文献求助10
6秒前
6秒前
orixero的应助被丁丁采纳,获得10
6秒前
Lucas的应助被AquaticLily采纳,获得40
6秒前
7秒前
7秒前
7秒前
鱼梓完成签到,获得积分10
7秒前
Nole的应助被DW采纳,获得10
8秒前
领导范儿的应助被DingZC采纳,获得10
8秒前
Lee256965510发布了新的文献求助10
9秒前
深情安青的应助被仂尤采纳,获得10
10秒前
纯真的豌豆完成签到,获得积分10
10秒前
完美世界的应助被艾妮吗采纳,获得10
11秒前
含蓄语兰完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188221
求助须知:如何正确求助?哪些是违规求助? 9576025
关于积分的说明 21845049
捐赠科研通 7786165
什么是DOI,文献DOI怎么找? 3435226
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482157